Severe anemia is common and undertreated in adults with advanced kidney disease

NewsGuard 100/100 Score

In an analysis of outpatient data from over 5 million adults, hemoglobin level was < 10 g/dl in over 20% with advanced kidney disease but less than 4% were treated with erythpoiesis-stimulating agents and iron testing was infrequent.

Anemia, a common complication of chronic kidney disease, is associated with adverse outcomes. Unfortunately, the use of erythropoiesis-stimulating agents (ESAs) to target a normal hemoglobin level has been associated with increased cardiovascular risk. This large study of over 5 million patients sought to describe the burden and risk factors associated with anemia by estimated glomerular filtration rate (eGFR) level.

In a study published in the American Journal of Kidney Diseases, researchers found that severe anemia was common and strongly associated with lower eGFR and multiple adverse outcomes. ESA use was rare. Although iron studies were checked infrequently, low iron test results were common in those tested. This highlights the need for increased testing of iron studies in patients with anemia, as iron supplementation is an effective and low-risk intervention.

Source:
Journal reference:

Farrington, D.K., et al. (2022) Anemia Prevalence, Type, and Associated Risks in a Cohort of 5.0 Million Insured Patients in the United States by Level of Kidney Function. American Journal of Kidney Diseases. doi.org/10.1053/j.ajkd.2022.07.014.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Combining blood pressure drug with dietary-resistant starch may help stave off diabetic kidney disease